Medication Training Via Ignite Based on Roy Model in Heart Failure: Medication Adherence and Symptom Management
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Ignite-Based Medication Management Training.
- Who it may be relevant to
- Registry conditions: Hearth Failure With Reduced Ejection Fraction (HFrEF). Basic parameters: 18 years — 65 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Turkey (Türkiye)
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
The Effect of Medication Management Training Delivered Via the Digital Presentation Format Ignite, Based on the Roy Adaptation Model, on Medication Adherence and Symptom Management in Individuals Diagnosed With Heart Failure
Overview
The goal of this clinical trial is to learn if a structured medication training program can help people with heart failure better manage their condition. The program is based on the Roy Adaptation Model and is designed to support how people adjust to their illness. The main questions it aims to answer are: Does the training program improve heart failure symptoms? Does the training program help participants take their medications as prescribed? Researchers will compare a training program group to a control group receiving standard care to see if the program is effective. Participants will: Be randomly assigned to either a training program group or a control group Receive the training program through WhatsApp after hospital discharge or receive standard discharge education Be followed for 12 weeks Complete questionnaires at the start of the study, at 4 weeks, and at 12 weeks
Detailed description
This study is a structured, theory-based randomized controlled trial designed to evaluate adaptation and self-management in patients with heart failure following hospital discharge.
The study is based on the Roy Adaptation Model, which conceptualizes individuals as adaptive systems responding to internal and external stimuli through four adaptive modes: physiological, self-concept, role function, and interdependence. This theoretical framework guides the development and implementation of the intervention.
The intervention consists of a structured digital medication management training program delivered after discharge. The program aims to improve medication adherence, enhance patients' understanding of their treatment regimens, and support adaptive responses to the challenges of living with heart failure. The educational content is standardized and provided through a remote format to ensure consistency and accessibility.
Participants will be assigned to intervention and control groups. While the intervention group receives the structured digital training program, the control group receives standard care.
Data will be collected at baseline and follow-up time points using validated instruments to assess adaptation and self-management behaviors. The study aims to determine the effectiveness of the intervention in improving patients' adaptation to heart failure and their ability to manage their condition.
Interventions
- Other Ignite-Based Medication Management Training
The intervention is a structured medication management training program based on the Roy Adaptation Model. It is delivered using an Ignite digital presentation format and sent to participants via WhatsApp. The content is developed using current evidence-based heart failure guidelines (AHA and ESC) and focuses on improving patients' adaptation to illness through four adaptive modes (physiological, self-concept, role function, and interdependence). Participants receive the training after dischar
Primary outcome measures
- Heart Failure Symptom Status Scale [Time frame: 20 minutes]
Secondary outcome measures (1)
- Medication Adherence Report Scale [Time frame: 5 minutes]
Eligibility criteria
Inclusion criteria
- Must be 18 years of age or older.
- Individuals who are willing to participate in the study
- No communication problems
- Having been diagnosed with KY for at least 6 months
- Having the ability to read, write and speak Turkish .
- Mildly reduced ejection fraction (left ventricular EF 41-49%)
- Individuals with WhatsApp application
- Individuals who can use a smartphone
Exclusion criteria
- Not being willing to participate in the study don't be under the age of 18
- Lack of ability to read, write and speak Turkish
- Low ejection fraction (left ventricle EF. 40%)
- Preserved ejection fraction (left ventricular EF.50%)
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Open label
- Primary purpose
- Treatment
Study locations
Turkey (Türkiye) · 1 center
- Suleyman Yalcin City Hospital — Istanbul
Identifiers
NCT: NCT07538596 · E-46418926-050.04--539411